Induction of pluripotency by defined factors (Q37737383)

22 August 2017

1 reference

title

Induction of pluripotency by defined factors (English)

1 reference

22 August 2017

1 reference

2

Shinya Yamanaka

1 reference

22 August 2017

1

Keisuke Okita

1 reference

PubMed ID

20420827

22 August 2017

language of work or name

English

0 references

publication date

24 April 2010

1 reference

Experimental Cell Research

22 August 2017

1 reference

22 August 2017

316

1 reference

22 August 2017

16

1 reference

22 August 2017

2565-2570

1 reference

Viable offspring derived from fetal and adult mammalian cells

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Plat-E: an efficient and stable system for transient packaging of retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Generation of germline-competent induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Induced pluripotent stem cell lines derived from human somatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Direct cell reprogramming is a stochastic process amenable to acceleration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Tbx3 improves the germ-line competency of induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Core transcriptional regulatory circuitry in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Polycomb complexes repress developmental regulators in murine embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Role of the murine reprogramming factors in the induction of pluripotency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Generation of pluripotent stem cells from adult mouse liver and stomach cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Reprogramming of pancreatic beta cells into induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Reprogramming towards pluripotency requires AID-dependent DNA demethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Variation in the safety of induced pluripotent stem cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Disease-specific induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

iPS cells produce viable mice through tetraploid complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

iPS cells can support full-term development of tetraploid blastocyst-complemented embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.023

10.1016/J.YEXCR.2010.04.023

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20420827